blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1778271

EP1778271 - PEPTIDES FOR THE TREATMENT OF HERPES VIRUS INFECTIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.08.2009
Database last updated on 02.07.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY, TR
published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
IPF Pharmaceuticals GmbH
Feodor-Lynen-Str. 31
30625 Hannover / DE
[2007/18]
Inventor(s)01 / FORSSMANN, Wolf-Georg
Kaiser-Wilhelm-Str. 23A
30559 Hannover / DE
02 / KIRCHHOFF, Frank
Schmiedgasse 21-3
89077 Ulm / DE
03 / MÜNCH, Jan
Weserstr. 6
89231 Neu-Ulm / DE
04 / STÄNDKER, Ludger
Schlegelplatz 1
30625 Hannover / DE
 [2008/42]
Former [2007/18]01 / FORSSMANN, Wolf-Georg
Kaiser-Wilhelm-Str. 23A
30559 Hannover / DE
02 / KIRCHHOFF, Frank
Schmiedgasse 21-3
89077 Ulm / DE
03 / MÜNCH, Jan
Einsteinstrasse 17-2
89077 Ulm / DE
04 / STÄNDKER, Ludger
Schlegelplatz 1
30625 Hannover / DE
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2007/18]Meyers, Hans-Wilhelm
Patentanwälte von Kreisler-Selting-Werner Postfach 10 22 41
50462 Köln / DE
Application number, filing date05786951.316.08.2005
[2007/18]
WO2005EP54028
Priority number, dateEP2004001955218.08.2004         Original published format: EP 04019552
US20040602313P18.08.2004         Original published format: US 602313 P
[2007/18]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006018431
Date:23.02.2006
Language:EN
[2006/08]
Type: A2 Application without search report 
No.:EP1778271
Date:02.05.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 23.02.2006 takes the place of the publication of the European patent application.
[2007/18]
Type: B1 Patent specification 
No.:EP1778271
Date:22.10.2008
Language:EN
[2008/43]
Search report(s)International search report - published on:EP08.06.2006
ClassificationIPC:A61K38/01, A61K38/17, A61P31/22
[2007/18]
CPC:
A61K38/1709 (EP,US); A61K38/017 (EP,US); A61P31/12 (EP);
A61P31/22 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/18]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:PEPTIDE ZUR BEHANDLUNG VON INFEKTIONEN MIT DEM HERPES-VIRUS[2007/18]
English:PEPTIDES FOR THE TREATMENT OF HERPES VIRUS INFECTIONS[2007/18]
French:PEPTIDES POUR LE TRAITEMENT DES INFECTIONS HERPETIQUES[2007/18]
Entry into regional phase14.09.2006National basic fee paid 
14.09.2006Designation fee(s) paid 
14.09.2006Examination fee paid 
Examination procedure14.09.2006Amendment by applicant (claims and/or description)
14.09.2006Examination requested  [2007/18]
04.09.2007Despatch of a communication from the examining division (Time limit: M06)
16.01.2008Reply to a communication from the examining division
16.05.2008Communication of intention to grant the patent
04.09.2008Fee for grant paid
04.09.2008Fee for publishing/printing paid
Opposition(s)23.07.2009No opposition filed within time limit [2009/40]
Fees paidRenewal fee
29.08.2007Renewal fee patent year 03
28.03.2008Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT22.10.2008
BE22.10.2008
CY22.10.2008
CZ22.10.2008
EE22.10.2008
FI22.10.2008
IT22.10.2008
LT22.10.2008
LV22.10.2008
PL22.10.2008
RO22.10.2008
SI22.10.2008
SK22.10.2008
TR22.10.2008
BG22.01.2009
GR23.01.2009
ES02.02.2009
IS22.02.2009
PT23.03.2009
HU23.04.2009
[2011/43]
Former [2011/32]AT22.10.2008
BE22.10.2008
CZ22.10.2008
EE22.10.2008
FI22.10.2008
IT22.10.2008
LT22.10.2008
LV22.10.2008
PL22.10.2008
RO22.10.2008
SI22.10.2008
SK22.10.2008
BG22.01.2009
GR23.01.2009
ES02.02.2009
IS22.02.2009
PT23.03.2009
HU23.04.2009
Former [2011/01]AT22.10.2008
BE22.10.2008
CZ22.10.2008
EE22.10.2008
FI22.10.2008
IT22.10.2008
LT22.10.2008
LV22.10.2008
PL22.10.2008
RO22.10.2008
SI22.10.2008
SK22.10.2008
BG22.01.2009
GR23.01.2009
ES02.02.2009
IS22.02.2009
PT23.03.2009
Former [2010/01]AT22.10.2008
BE22.10.2008
CZ22.10.2008
EE22.10.2008
FI22.10.2008
IT22.10.2008
LT22.10.2008
LV22.10.2008
PL22.10.2008
RO22.10.2008
SI22.10.2008
SK22.10.2008
BG22.01.2009
ES02.02.2009
IS22.02.2009
PT23.03.2009
Former [2009/32]AT22.10.2008
BE22.10.2008
FI22.10.2008
LT22.10.2008
LV22.10.2008
PL22.10.2008
SI22.10.2008
BG22.01.2009
ES02.02.2009
IS22.02.2009
PT23.03.2009
Former [2009/28]AT22.10.2008
FI22.10.2008
LT22.10.2008
LV22.10.2008
PL22.10.2008
SI22.10.2008
BG22.01.2009
ES02.02.2009
IS22.02.2009
PT23.03.2009
Former [2009/21]LT22.10.2008
ES02.02.2009
Former [2009/20]ES02.02.2009
Cited inInternational search[A]JPS649997  ;
 [AD]WO0194386  (IPF PHARMACEUTICALS GMBH [DE], et al) [AD] * the whole document *;
 [A]GB2382347  (PANZERI EZIO [IE]) [A] * the whole document *;
 [PX]EP1481988  (IPF PHARMACEUTICALS GMBH [DE]) [PX] 1-7 * claims 1,8 *
 [A]  - PATENT ABSTRACTS OF JAPAN, (19890427), vol. 013, no. 182, Database accession no. (C - 591), & JP01009997 A 19890113 (TORAY IND INC) [A] * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.